Depression is common and there are effective treatment options to help you feel better. We're going to talk about the ...

The notice was received by the China National Intellectual Property AdministrationVancouver, Canada, Nov. 12, 2025 (GLOBE NEWSWIRE) -- ...

Patent expands MEAI’s global intellectual property protection as Clearmind advances clinical development and commercialization plansVancouver, ...

Moment of Clarity has published a new educational resource titled “Acccelerated TMS Therapy for Depression“, providing an in-depth look at how transcranial magnetic stimulation (TMS) technology is ...

Scientists have explored creatine's potential to alleviate depressive symptoms, presenting a comprehensive systematic review and meta-analysis published recently in the British Journal ...

(NASDAQ: STIM), a medical technology company focused on designing, developing, and marketing products that improve the quality of life for patients who suffer from neurohealth disorders and the maker ...

The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive ...

Samson Clinical ( Samson ), an Australian pharmaceutical company focused on developing innovative treatments for hair loss, today announced the successful completion of recruitment ...

The VA is expanding psychedelic-assisted therapy trials for PTSD and depression at nine facilities, exploring new hope for ...

Thriveworks reports seasonal depression peaks in the third week of November, with symptoms affecting cities that experience ...

Rapid Onset: A conservative nalmefene concentration target—representing the threshold effect for protection from respiratory depression—was projected to be achieved in approximately 30 minutes ...

As daylight fades, many experience fatigue or low mood—but for millions, these symptoms signal seasonal affective disorder (SAD), a serious form of depression.